Key result
Losartan administration during suckling in stroke-prone spontaneously hypertensive rats significantly increased life span (104±78 vs 37±17 days) after salt loading.
Why the study?
Does early treatment with an AT1 receptor antagonist during suckling reduce salt sensitivity and improve life span in stroke-prone spontaneously hypertensive rats?
Does early treatment with an AT1 receptor antagonist during suckling reduce salt sensitivity and improve life span in stroke-prone spontaneously hypertensive rats?
Answers are grounded in this paper and cite their sources.
Early administration of an AT1 receptor antagonist during suckling reduces salt sensitivity and prolongs life span in stroke-prone spontaneously hypertensive rats.
BACKGROUND: In this study, antihypertensive therapy was started during suckling and the effect on blood pressure (BP) and salt sensitivity of stroke-prone spontaneously hypertensive rats (SHRSP) was determined. METHODS: The SHRSP were treated with an AT1 receptor antagonist (losartan: 100 mg/L in drinking water) from 2 to 4 weeks of age. After stopping treatment at 4 weeks of age, the control group and the losartan group were fed a commercial diet with tap water ad libitum until 10 weeks of age. Both the control and losartan groups were switched to 1% saline at the age of 10 weeks. RESULTS: Salt loading was started at 10 weeks of age, with BP levels of 203+/-3 and 199+/-6 mm Hg for the control group and the losartan group, respectively, at that age. After 4 weeks of salt loading, BP levels were 253+/-7 mm Hg in the control group and 242+/-5 mm Hg in the losartan group, showing a mild elevation in the losartan group. The life span of the losartan group (104+/-78 days) was significantly greater than that of the control group (37+/-17 days). Plasma aldosterone concentrations of the losartan group were lower than those of the control group at 4 and 15 weeks of age. CONCLUSIONS: We have demonstrated the renin-angiotensin-aldosterone system may play a key role in the establishment of end-organ salt sensitivity, and the period of lactation in critical for salt sensitivity in later life.
No takes yet. Share an insight, caveat, or question.
Otani et al. (2006) studied Hypertension and salt sensitivity. AT1 receptor antagonist (losartan) vs. Control group was evaluated on Life span after salt loading. Losartan administration during suckling in stroke-prone spontaneously hypertensive rats significantly increased life span (104±78 vs 37±17 days) after salt loading.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: